Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of concept in man.
Bukara K, Schueller L, Rosier J, Martens MA, Daems T, Verheyden L, Eelen S, Van Speybroeck M, Libanati C, Martens JA, Van Den Mooter G, Frérart F, Jolling K, De Gieter M, Bugarski B, Kiekens F.
Bukara K, et al. Among authors: jolling k.
Eur J Pharm Biopharm. 2016 Nov;108:220-225. doi: 10.1016/j.ejpb.2016.08.020. Epub 2016 Sep 17.
Eur J Pharm Biopharm. 2016.
PMID: 27648957
Clinical Trial.